Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Atezolizumab in Metastatic Triple-Negative Breast Cancer: IMpassion130 and 131 Trials – How to Explain Different Results?ESMO Open 2020 Nov 01;5(6)1-4, MA Franzoi, E de Azambuja
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.